Extensive preclinical research shows TB-500 stimulates angiogenesis, promotes wound healing, reduces inflammation, inhibits apoptosis, and enhances tissue perfusion in models of muscle, tendon, ligament, and dermal injury
Remarkably, all 12 patients reported significant improvement in symptoms and none reported adverse effects in the short term
In some cases, injections may be required to achieve normal levels
Chronic treatment should be with an oral B 12 preparation
It is not approved by the FDA for human or veterinary use, and it is not intended to diagnose, treat, cure, or prevent any disease
The manufactured products under investigation are the USP, 30 mL, multi-dose vial, lot W20308